DBP (D-box binding PAR bZIP transcription factor) is a circadian clock-controlled transcription factor that regulates metabolic and detoxification pathways. DBP functions as a transcriptional activator by recognizing and binding to specific D-box sequences (5'-RTTAYGTAAY-3') in target gene promoters 1. The protein plays a crucial role in regulating drug-metabolizing enzymes, particularly CYP3A4 and CYP2C19, with studies showing that DBP expression correlates with these cytochrome P450 enzymes in human liver tissue 1. DBP expression is significantly reduced in omental adipose tissue of patients with type 2 diabetes mellitus, where it regulates PPAR-γ expression and subsequently affects adiponectin secretion and insulin sensitivity 2. This regulation involves histone H3K9 acetylation at the DBP promoter region, which is decreased in diabetic patients 2. The DBP gene is organized into 13 exons and 12 introns, sharing structural similarity with other members of the albumin gene family 3. DBP's role in drug metabolism makes it clinically relevant for understanding individual responses to medications, particularly benzodiazepines, where altered DBP expression may affect drug clearance and efficacy 1.